Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Obama: Ebola Still Priority as Public Focus Shifts

By R&D Editors | December 2, 2014

President Barack Obama speaks to the media about Ebola, Tuesday, Oct. 28, 2014, on the South Lawn of the White House in Washington before boarding Marine One for a short trip to Andrews Air Force Base, Md., then onto Wisconsin for a campaign stop. The president said the US can't be seen as shying away from battle against Ebola. Obama did not directly criticize quarantine policies for returning health care workers implemented in New York and New Jersey. But he says the response to Ebola needs to be sensible and "based on science," while supporting health care workers going overseas to fight the disease. (AP Photo/Jacquelyn Martin)

Declaring the “fight is nowhere close to being over,” President Barack Obama on Tuesday heralded strides in the effort to confront Ebola in West Africa and in protecting the U.S. against the spread of the deadly virus. He said squelching the disease remains an urgent priority even if the American public’s attention has shifted elsewhere.

“We cannot let down our guard, even for minute,” Obama said. “We can’t just fight this epidemic, we have to extinguish it.”

Obama spoke after touring the National Institutes of Health in Washington’s Maryland suburbs where he witnessed advances in Ebola-fighting research. He highlighted the NIH’s progress in developing an Ebola vaccine, calling the initial results “exciting” while cautioning that there are “no guarantees” about the vaccine’s ultimate success.

NIH researchers last week reported that the first safety study of a vaccine candidate found no serious side effects, and that it triggered signs of immune protection in 20 volunteers. U.S. health officials are planning much larger studies in West Africa to try to determine if the shots really work.

“No potential Ebola vaccine has ever made it this far,” Obama said.

He prodded Congress to approve his request for $6.2 billion in emergency spending against the outbreak, urging lawmakers to act before they break for the holidays.

“We can’t beat Ebola without more funding,” he said. “It’s a good Christmas present to the American people and to the world.”

The public attention to Ebola by the president comes as Congress is assembling a massive spending bill to keep the government operating. But the legislation has become entangled with Obama’s executive actions on immigration, which Republicans want to block.

Any final spending bill is expected to contain a pared down version of Obama’s Ebola request. Obama asked for $2 billion for the United States Agency for International Development, $2.4 billion for the Department of Health and Human Services, and more than $1.5 billion for a contingency fund, the first item that lawmakers would likely trim.

The White House said Tuesday that Ebola Response Coordinator Ron Klain, in an update to Obama, reported that the U.S. is better prepared to deal with Ebola at home and that administration efforts to confront the virus in Liberia, Guinea and Sierra Leone are further along than two months ago.

Obama called attention to the administration’s announcement Tuesday that it has set up a network of 35 hospitals across the country to deal with Ebola patients. It also said that the number of labs that can test for Ebola has increased from 13 in 13 states in August to 42 labs in 36 states.

The White House said the administration has also increased the deployment of civilians and military personnel in West Africa, bumping the U.S. presence to about 200 civilians and 3,000 troops. It said the U.S. has opened three Ebola treatment units and a hospital in Liberia.

The upbeat White House report contrasts with an assessment from Doctors Without Borders, which said Tuesday that the international response to the Ebola crisis in West Africa has been slow and uneven. It said the international community has for the most part concentrated on building Ebola management structures, but most of the hands-on work is being done by local people, national governments and non-governmental organizations.

Obama stressed the role of science while praising the medical advances against the disease, a not-too subtle rebuke of what the White House maintained was over-reaction by some politicians to the threat of Ebola in the United States.

“The basic concept of science, and making judgments on the basis of evidence, that’s what’s most needed during difficult, challenging moments like the ones that we had this summer and that we continue to have in West Africa,” he said.

Source: Associated Press

Related Articles Read More >

For the first time, scientists grow beating human-pig hearts for 21 days
Open-source Boltz-2 can speed binding-affinity predictions 1,000-fold
Thermo Fisher’s new Orbitrap Excedion Pro targets complex biotherapeutics for drug development
FDA’s new ‘Elsa’ AI set to expedite clinical protocol reviews
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE